World Alzheimer’s Day 2022

Ventio participates to the follow-up of Alzheimer’s disease patients by offering a patented, innovative and quantitative technology for the follow-up of neuronal lesions by cerebral imaging: the Quantitative Susceptibility Mapping (QSM) technology.  

Ventio, with the QSM technology, is alongside Neurospin, the brain imaging innovation research center of the French Alternative Energies and Atomic Energy Commission (CEA) with QSM4SENIOR project. This project is driven by the laboratory BAOBAB, to couple the innovating QSM technology to NeuroSpin imaging system and identify predictive biomarkers and new therapeutic targets for neurodegenerative diseases such as Alzheimer’s disease.

For the « World Alzheimer’s Day », Ventio offers a selection of scientific publications about QSM :

Health professionals, neurology and neuroimaging departments, research laboratories and drug companies, contact us for more information.